BackgroundIn breast cancers. only a minority of patients fully benefit from the different chemotherapy regimens currently in use. Identification of markers that could predict the response to a particular regimen would thus be critically important for patient care. In cell lines or animal models. https://www.hcbcyouthleadersummit.com/product-category/hair-loss-treatment/